• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchCoya Therapeutics
    Picture of Coya Therapeutics logo

    COYA — Coya Therapeutics Share News

    $3.940.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousSmall CapNeutral
    • Market Cap
      $92.42m
    • Enterprise Value
      $49.24m
    • Revenue
      $7.95m
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • COYA Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    COYA Dividends
    • Chardan initiates Coya Therapeutics with 'buy'

      26/01/2023 19:21
    • Brief: Coya Therapeutics, Inc. Announces Preclinical Data Supporting The Role Of Expanded Regulatory T Cells (Tregs) As Potential Disease-Modifying Treatment In An Animal Model Of Alzheimer’S Disease (Ad)

      26/01/2023 14:05
    • Coya Therapeutics falls after $15 mln IPO

      29/12/2022 18:51
    Previous12345Next

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.